W. Anthony Vernon
At a glance: W. Anthony Vernon is Director at NovoCure (NVCR). Their latest SEC Form 4, filed Jun 3, 2026, reported a sale of $46K. On file: 0 purchase lines ($0) and 1 sale line ($46K).
Disclosed holdings: about $2.1M of NVCR stock: 197,657 shares reported on their latest Form 4 (filed Jun 3, 2026), valued at the Nov 19, 2026 close of $10.65. This counts only NVCR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at NovoCure Ltd (NVCR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
Follow W. Anthony Vernon
Get one email when W. Anthony Vernon files a new purchase or sale. Free.
At most one email a day about W. Anthony Vernon, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.